TRIG1 - Overview: Triglycerides, Serum
Managing atherosclerotic cardiovascular disease risk
ULFA - Overview: Cryptococcus Antigen Screen, Lateral Flow Assay, Random, Urine
Aiding in the diagnosis of infection with Cryptococcus neoformans or Cryptococcus gattii This test should not be used as a test of cure. This test should not be used as a screening procedure for the general population.
SEAS - Overview: Seasonal Inhalants Allergen Profile, Serum
Establishing a diagnosis of an allergy to seasonal inhalants Defining the allergen responsible for eliciting signs and symptoms Identifying allergens: -Responsible for allergic response and/or anaphylactic episode -To confirm...
RBR - Overview: Retinol-Binding Protein, Random, Urine
Assessing renal tubular injury or dysfunction using random urine collections Screening for other tubular abnormalities Detecting chronic asymptomatic renal tubular dysfunction.(2)
VLTBX - Overview: Volatile Screen, Chain of Custody, Blood
Detection and quantitation of acetone, methanol, isopropanol, and ethanol in whole blood Quantification of the concentration of ethanol in blood that correlates with the degree of intoxication Evaluation of toxicity to the measured...
MUMPU - Overview: Mumps Virus, Molecular Detection, PCR, Random, Urine
Rapid qualitative detection of mumps virus using random urine specimens
EDN - Overview: Eosinophil Derived Neurotoxin, Serum
Evaluating patients suspected to have a condition associated with eosinophilia or hypereosinophilia Evaluating patients with elevated peripheral blood eosinophil counts Managing patients with elevated eosinophil-derived neurotoxin in the...
ZNU - Overview: Zinc, 24 Hour, Urine
Identifying the cause of abnormal serum zinc concentrations using a 24-hour urine specimen
PNYA - Overview: Phenytoin, Total, Serum
Monitoring for appropriate therapeutic concentration Assessing compliance or toxicity
MESOP - Overview: Mesothelioma Panel (WT1/KRT5/TTF1/pCEA) Immunostain, Technical Component Only
Differentiation of mesothelioma and non-small cell lung cancer
Primary ciliary dyskinesia - Insights
Learn more about Mayo Clinic Laboratories’ robust approach to testing for primary ciliary dyskinesia, a rare genetic condition that can lead to chronic otosinopulmonary disease and infertility in men....
https://www.mayocliniclabs.com/it-mmfiles/cpt-code-changes.xlsx
note, CPT Code changes listed on this document are effective January 1st, 2025.*** ***Updates and other changes may occur, and be reflected on this document, leading up to 2025*** ***CPT Code Updates...
CPT Codes and LOINC Update: September 2019 - Insights
View a full list of new CPT codes, Test Classification Updates, LOINC Codes, and Z-Codes posted to mayocliniclabs.com during the month of September 2019....
MCL Primary Ciliary Dyskinesia Genetic Testing Patient Information MC1235297
MCL Primary Ciliary Dyskinesia Genetic Testing Patient Information Complete print Reset Form Primary Ciliary Dyskinesia Genetic Testing Patient Information Instructions Accurate interpretation reporting...
New communication process for CPT Code changes - Insights
Mayo Clinic Laboratories (MCL) is pleased to announce an essential update to our CPT code communication process and website layout. This change is designed to bring timely notifications for accurate billing...